Stockreport

Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely [Yahoo! Finance]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF Therapeutics, Inc. (NASDAQ:FDMT) has a ‘Buy' or equivalent rating from 82% of the analysts covering the stock. While the price target ranges from $17 to $45, the one-yea [Read more]